QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
NASDAQ:BBH

VanEck Biotech ETF - BBH Price, Holdings, & News

$158.17
+0.82 (+0.52%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$157.47
▼
$158.52
50-Day Range
$151.32
▼
$164.91
52-Week Range
$131.12
▼
$170.25
Volume
8,036 shs
Average Volume
10,899 shs
Market Capitalization
$506.14 million
Assets Under Management
$481.70 million
Dividend Yield
0.47%
Net Expense Ratio
0.35%
BBH stock logo

About VanEck Biotech ETF (NASDAQ:BBH)

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

Receive BBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

BBH ETF News Headlines

March 18, 2023 | morningstar.com
VanEck Biotech ETF BBH
March 11, 2023 | americanbankingnews.com
VanEck Biotech ETF (NASDAQ:BBH) Short Interest Update
March 21, 2023 | Investing Daily (Ad)
How This Trader Banked A 97% Win Rate
Despite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. pixel
December 23, 2022 | msn.com
VanEck Vectors Biotech ETF declares annual distribution of $0.7488
November 26, 2022 | nasdaq.com
Biotech Finally Getting Its Groove Back
October 21, 2022 | seekingalpha.com
IBB iShares Biotechnology ETF
September 7, 2022 | nasdaq.com
Consolidation Case for Biotech ETF BBH
August 25, 2022 | uk.finance.yahoo.com
VanEck Biotech ETF (BBH)
March 21, 2023 | Investing Daily (Ad)
How This Trader Banked A 97% Win Rate
Despite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. pixel
August 17, 2022 | nasdaq.com
Biotech Bounce-Back Could Be Durable
See More Headlines
Receive BBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Van Eck
Fund Name
VanEck Biotech ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:BBH
Inception Date
12/20/2011
Fund Manager
Hao-Hung Peter Liao, Guo Hua Jason Jin
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Market Vectors US Listed Biotech 25 Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
Global
Number of Holdings
26

Fund Statistics

Assets Under Management
$481.70 million
Average Daily Volume
$14,937.10
Discount/Premium
12.84%

Administrator, Advisor and Custodian

Administrator
Van Eck Associates Corporation
Advisor
Van Eck Associates Corporation
Custodian
State Street Bank and Trust Company
Distributor
Van Eck Securities Corporation
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
2
Put Options
2
Call Options
1
Short Interest
2,200 shs

Miscellaneous

Outstanding Shares
3,200,000
Beta
0.84
Creation Unit
50,000
Creation Fee
$500.00

VanEck Biotech ETF Expenses

TypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.35%0.56%0.52%0.45%0.49%
Other Expenses0.00%0.35%0.52%0.34%0.55%
Total Expense0.35%0.70%0.68%0.57%0.68%
Fee Waiver0.00%-0.38%-0.56%-0.35%-0.58%
Net Expense0.35%0.61%0.58%0.50%0.56%

VanEck Biotech ETF (BBH) Holdings & Exposure

Top 10 BBH Holdings

BBH Sector Exposure

BBH Industry Exposure

Full Holdings Details













BBH ETF - Frequently Asked Questions

How have BBH shares performed in 2023?

VanEck Biotech ETF's stock was trading at $159.74 on January 1st, 2023. Since then, BBH shares have decreased by 1.0% and is now trading at $158.17.
View the best growth stocks for 2023 here.

Are investors shorting VanEck Biotech ETF?

VanEck Biotech ETF saw a drop in short interest in February. As of February 28th, there was short interest totaling 2,200 shares, a drop of 74.1% from the February 13th total of 8,500 shares. Based on an average daily trading volume, of 11,000 shares, the days-to-cover ratio is presently 0.2 days.
View VanEck Biotech ETF's Short Interest.

How often does VanEck Biotech ETF pay dividends? What is the dividend yield for VanEck Biotech ETF?

VanEck Biotech ETF announced an annual dividend on Friday, December 16th. Stockholders of record on Tuesday, December 20th will be paid a dividend of $0.749 per share on Friday, December 23rd. This represents a dividend yield of 0.47%. The ex-dividend date of this dividend is Monday, December 19th. This is a boost from the stock's previous annual dividend of $0.40.
Read our dividend analysis for BBH.

What does BBH invest in?

VanEck Biotech ETF is a equity fund issued by Van Eck. BBH focuses on health care investments and follows the Market Vectors US Listed Biotech 25 Index. The fund's investments total to approximately $481.70 million assets under management.

What stocks does VanEck Biotech ETF hold?

BBH invests in 26 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Amgen (AMGN), Gilead Sciences (GILD), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Regeneron Pharmaceuticals (REGN), IQVIA (IQV) and IQVIA (IQV).

What is the management fee for VanEck Biotech ETF?

VanEck Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for BBH is 0.35%.

What other stocks do shareholders of VanEck Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Sanofi (SNY), Intel (INTC), Micron Technology (MU), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Novavax (NVAX).

What is VanEck Biotech ETF's stock symbol?

VanEck Biotech ETF trades on the NASDAQ under the ticker symbol "BBH."

Who are VanEck Biotech ETF's major shareholders?

VanEck Biotech ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Morgan Stanley (2.37%), JPMorgan Chase & Co. (2.34%), LPL Financial LLC (1.56%), Bank of America Corp DE (1.24%), Mogy Joel R Investment Counsel Inc. (1.11%) and UBS Group AG (1.02%).

How do I buy shares of VanEck Biotech ETF?

Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is VanEck Biotech ETF's stock price today?

One share of BBH stock can currently be purchased for approximately $158.17.

How much money does VanEck Biotech ETF make?

VanEck Biotech ETF (NASDAQ:BBH) has a market capitalization of $506.14 million.

This page (NASDAQ:BBH) was last updated on 3/21/2023 by MarketBeat.com Staff